Skip to main content
Premium Trial:

Request an Annual Quote

EMD Biosciences to Offer Reagents for TAP s Automated Protein Production System

NEW YORK, June 22 (GenomeWeb News) - EMD Biosciences will offer protein purification reagents for an automated protein production system from The Automation Partnership, the company said today.

 

Under the strategic partnership, EMD will combine its Novagen-brand cell culture, lysis, and affinity purification reagents with TAP's Piccolo system for the automated production of recombinant proteins.

 

EMD, based in Madison, Wis., belongs to Darmstadt, Germany-based Merck. The company operates as EMD Biosciences in North American and as Merck Biosciences elsewhere. TAP is headquartered in Cambridge, UK.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.